脑肠行为治疗对肠易激综合征腹痛的疗效:系统综述与网络Meta分析
该系统综述与网络Meta分析检索至2023年12月16日的随机对照试验,纳入42项试验共5220例成人肠易激综合征患者,评估脑肠行为治疗对腹痛缓解或改善的疗效。自助/最少接触认知行为疗法、面对面多成分行为疗法和面对面肠道导向催眠疗法可能有效,但彼此间无优劣之分。
要点
- 自助/最少接触认知行为疗法对腹痛未改善的RR为0.71(95%CI 0.54-0.95)。
- 面对面多成分行为疗法RR为0.72(95%CI 0.54-0.97)。
- 面对面肠道导向催眠疗法RR为0.77(95%CI 0.61-0.96)。
核心结论
- 自助/最少接触认知行为疗法、面对面多成分行为疗法和面对面肠道导向催眠疗法等脑肠行为治疗可能对肠易激综合征腹痛有效,但无一优于另一种。
研究设计与样本
- 系统综述与网络Meta分析,检索截至2023年12月16日的文献,纳入42项随机对照试验共5220例成人肠易激综合征患者,比较脑肠行为治疗之间或与对照干预的疗效。
主要发现
- 自助/最少接触认知行为疗法对腹痛未改善的RR为0.71(95%CI 0.54-0.95),P评分为0.58。
- 面对面多成分行为疗法对腹痛未改善的RR为0.72(95%CI 0.54-0.97),P评分为0.56。
- 面对面肠道导向催眠疗法对腹痛未改善的RR为0.77(95%CI 0.61-0.96),P评分为0.49。
- 在仅纳入难治性整体肠易激综合征症状患者的试验中,团体认知行为疗法对腹痛优于常规护理,但未检测到其他显著差异。
临床怎么用
- 美国管理指南建议对持续性腹痛的肠易激综合征患者使用脑肠行为治疗。
局限性
- 无试验在所有领域均为低偏倚风险。
- 存在漏斗图不对称的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Some brain-gut behavioral treatments (BGBTs) are beneficial for global symptoms in irritable bowel syndrome (IBS). United States management guidelines suggest their use in patients with persistent abdominal pain, but their specific effect on this symptom has not been assessed systematically. METHODS: We searched the literature through December 16, 2023, for randomized controlled trials (RCTs) assessing efficacy of BGBTs for adults with IBS, compared with each other or a control intervention. Trials provided an assessment of abdominal pain resolution or improvement at treatment completion. We extracted data as intention-to-treat analyses, assuming dropouts to be treatment failures and reporting pooled relative risks (RRs) of abdominal pain not improving with 95% confidence intervals (CIs), ranking therapies according to the P score. RESULTS: We identified 42 eligible randomized controlled trials comprising 5220 participants. After treatment completion, the BGBTs with the largest numbers of trials and patients recruited demonstrating efficacy for abdominal pain, specifically, included self-guided/minimal contact cognitive behavioral therapy (CBT) (RR, 0.71; 95% CI, 0.54-0.95; P score, 0.58), face-to-face multicomponent behavioral therapy (RR, 0.72; 95% CI, 0.54-0.97; P score, 0.56), and face-to-face gut-directed hypnotherapy (RR, 0.77; 95% CI, 0.61-0.96; P score, 0.49). Among trials recruiting only patients with refractory global IBS symptoms, group CBT was more efficacious than routine care for abdominal pain, but no other significant differences were detected. No trials were low risk of bias across all domains, and there was evidence of funnel plot asymmetry. CONCLUSIONS: Several BGBTs, including self-guided/minimal contact CBT, face-to-face multicomponent behavioral therapy, and face-to-face gut-directed hypnotherapy may be efficacious for abdominal pain in IBS, although none was superior to another.
引用
- Goodoory VC, Khasawneh M, Thakur ER, et al. Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis. Gastroenterology. 2024. PMID: 38777133. doi:10.1053/j.gastro.2024.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。